Literature DB >> 26297201

CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.

Tatiana Chirkova1, Songbai Lin1, Antonius G P Oomens2, Kelsey A Gaston1, Seyhan Boyoglu-Barnum1, Jia Meng1, Christopher C Stobart1, Calvin U Cotton3, Tina V Hartert4, Martin L Moore1, Assem G Ziady1, Larry J Anderson1.   

Abstract

Respiratory syncytial virus (RSV) is a major cause of severe pneumonia and bronchiolitis in infants and young children, and causes disease throughout life. Understanding the biology of infection, including virus binding to the cell surface, should help develop antiviral drugs or vaccines. The RSV F and G glycoproteins bind cell surface heparin sulfate proteoglycans (HSPGs) through heparin-binding domains. The G protein also has a CX3C chemokine motif which binds to the fractalkine receptor CX3CR1. G protein binding to CX3CR1 is not important for infection of immortalized cell lines, but reportedly is so for primary human airway epithelial cells (HAECs), the primary site for human infection. We studied the role of CX3CR1 in RSV infection with CX3CR1-transfected cell lines and HAECs with variable percentages of CX3CR1-expressing cells, and the effect of anti-CX3CR1 antibodies or a mutation in the RSV CX3C motif. Immortalized cells lacking HSPGs had low RSV binding and infection, which was increased markedly by CX3CR1 transfection. CX3CR1 was expressed primarily on ciliated cells, and ∼50 % of RSV-infected cells in HAECs were CX3CR1+. HAECs with more CX3CR1-expressing cells had a proportional increase in RSV infection. Blocking G binding to CX3CR1 with anti-CX3CR1 antibody or a mutation in the CX3C motif significantly decreased RSV infection in HAECs. The kinetics of cytokine production suggested that the RSV/CX3CR1 interaction induced RANTES (regulated on activation normal T-cell expressed and secreted protein), IL-8 and fractalkine production, whilst it downregulated IL-15, IL1-RA and monocyte chemotactic protein-1. Thus, the RSV G protein/CX3CR1 interaction is likely important in infection and infection-induced responses of the airway epithelium, the primary site of human infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26297201      PMCID: PMC4635495          DOI: 10.1099/vir.0.000218

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  73 in total

1.  Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection.

Authors:  Robert C Welliver; Roberto P Garofalo; Pearay L Ogra
Journal:  Pediatr Infect Dis J       Date:  2002-05       Impact factor: 2.129

2.  Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P.

Authors:  Lia M Haynes; Les P Jones; Albert Barskey; Larry J Anderson; Ralph A Tripp
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

3.  Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection.

Authors:  Ioannis Ioannidis; Beth McNally; Meredith Willette; Mark E Peeples; Damien Chaussabel; Joan E Durbin; Octavio Ramilo; Asuncion Mejias; Emilio Flaño
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

4.  Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1.

Authors:  C Combadiere; K Salzwedel; E D Smith; H L Tiffany; E A Berger; P M Murphy
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

5.  Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway.

Authors:  Bysani Chandrasekar; Srinivas Mummidi; Rao P Perla; Sailaja Bysani; Nickolai O Dulin; Feng Liu; Peter C Melby
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

6.  Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression.

Authors:  Miyuki Nishimura; Hisanori Umehara; Takashi Nakayama; Osamu Yoneda; Kunio Hieshima; Mayumi Kakizaki; Naochika Dohmae; Osamu Yoshie; Toshio Imai
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

7.  Role of f-box factor foxj1 in differentiation of ciliated airway epithelial cells.

Authors:  Yingjian You; Tao Huang; Edward J Richer; Jens-Erik Harboe Schmidt; Joseph Zabner; Zea Borok; Steven L Brody
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-06-20       Impact factor: 5.464

8.  Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine.

Authors:  C Combadiere; J Gao; H L Tiffany; P M Murphy
Journal:  Biochem Biophys Res Commun       Date:  1998-12-30       Impact factor: 3.575

9.  Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells.

Authors:  Rémi Villenave; Dara O'Donoghue; Surendran Thavagnanam; Olivier Touzelet; Grzegorz Skibinski; Liam G Heaney; James P McKaigue; Peter V Coyle; Michael D Shields; Ultan F Power
Journal:  Virol J       Date:  2011-01-27       Impact factor: 4.099

10.  Acceleration of epithelial cell syndecan-1 shedding by anthrax hemolytic virulence factors.

Authors:  Taissia G Popova; Bryan Millis; Chris Bradburne; Svetlana Nazarenko; Charles Bailey; Vikas Chandhoke; Serguei G Popov
Journal:  BMC Microbiol       Date:  2006-02-07       Impact factor: 3.605

View more
  55 in total

1.  Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues.

Authors:  Edita M Klimyte; Stacy E Smith; Pasqua Oreste; David Lembo; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

2.  Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.

Authors:  S Boyoglu-Barnum; S O Todd; J Meng; T R Barnum; T Chirkova; L M Haynes; S J Jadhao; R A Tripp; A G Oomens; M L Moore; L J Anderson
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

3.  Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells.

Authors:  B Cortjens; E Yasuda; X Yu; K Wagner; Y B Claassen; A Q Bakker; J B M van Woensel; T Beaumont
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

Review 4.  Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine.

Authors:  Dominik Hartl; Rabindra Tirouvanziam; Julie Laval; Catherine M Greene; David Habiel; Lokesh Sharma; Ali Önder Yildirim; Charles S Dela Cruz; Cory M Hogaboam
Journal:  J Innate Immun       Date:  2018-02-13       Impact factor: 7.349

5.  Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes.

Authors:  Stanislav O Fedechkin; Natasha L George; Ana M Nuñez Castrejon; Joshua R Dillen; Lawrence M Kauvar; Rebecca M DuBois
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

Review 6.  Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease.

Authors:  Homero San-Juan-Vergara; Mark E Peeples
Journal:  Immunol Allergy Clin North Am       Date:  2019-05-22       Impact factor: 3.479

7.  Respiratory syncytial virus infection of newborn CX3CR1-deficient mice induces a pathogenic pulmonary innate immune response.

Authors:  Sudipta Das; Mahesh Raundhal; Jie Chen; Timothy B Oriss; Rachael Huff; John V Williams; Anuradha Ray; Prabir Ray
Journal:  JCI Insight       Date:  2017-09-07

Review 8.  Development and clinical applications of novel antibodies for prevention and treatment of respiratory syncytial virus infection.

Authors:  Asuncion Mejias; Cristina Garcia-Maurino; Rosa Rodriguez-Fernandez; Mark E Peeples; Octavio Ramilo
Journal:  Vaccine       Date:  2016-09-28       Impact factor: 3.641

Review 9.  Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development.

Authors:  José A Melero; Vicente Mas; Jason S McLellan
Journal:  Vaccine       Date:  2016-09-28       Impact factor: 3.641

10.  Functional correlations of respiratory syncytial virus proteins to intrinsic disorder.

Authors:  Jillian N Whelan; Krishna D Reddy; Vladimir N Uversky; Michael N Teng
Journal:  Mol Biosyst       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.